Home / Resource Library / Nine-year Follow-up of Lenalidomide Plus Rituximab as Initial Treatment for Mantle Cell LymphomaNine-year Follow-up of Lenalidomide Plus Rituximab as Initial Treatment for Mantle Cell Lymphoma